Ceftobiprole medocaril (BAL5788) treatment of experimental Haemophilus influenzae, Enterobacter cloacae, and Klebsiella pneumoniae murine pneumonia
- 31 August 2006
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 55 (4), 333-336
- https://doi.org/10.1016/j.diagmicrobio.2006.01.029
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Antipneumococcal Activity of Ceftobiprole, a Novel Broad-Spectrum CephalosporinAntimicrobial Agents and Chemotherapy, 2005
- Evaluation of Ceftobiprole in a Rabbit Model of Aortic Valve Endocarditis Due to Methicillin-Resistant and Vancomycin-Intermediate Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2005
- Single-Dose Pharmacokinetics and Safety of a Novel Broad-Spectrum Cephalosporin (BAL5788) in Healthy VolunteersAntimicrobial Agents and Chemotherapy, 2004
- Efficacy of BAL5788, a Prodrug of Cephalosporin BAL9141, in a Mouse Model of Acute Pneumococcal PneumoniaAntimicrobial Agents and Chemotherapy, 2004
- In vitro activity of BAL9141 against clinical isolates of gram-negative bacteriaDiagnostic Microbiology and Infectious Disease, 2004
- Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical CenterJournal of Antimicrobial Chemotherapy, 2003
- In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococciJournal of Antimicrobial Chemotherapy, 2002
- BAL9141, a Novel Extended-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococcus aureus in Treatment of Experimental EndocarditisAntimicrobial Agents and Chemotherapy, 2002
- In Vitro and In Vivo Properties of Ro 63-9141, a Novel Broad-Spectrum Cephalosporin with Activity against Methicillin-Resistant StaphylococciAntimicrobial Agents and Chemotherapy, 2001
- Ketolide Treatment of Haemophilus influenzae Experimental PneumoniaAntimicrobial Agents and Chemotherapy, 1999